Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Reexamination Certificate
2006-01-03
2006-01-03
Stucker, Jeffrey (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
C424S184100, C424S216100, C424S278100
Reexamination Certificate
active
06982088
ABSTRACT:
The invention concerns the stabilization of a vaccine composition maintained in liquid state by the use of high molecular weight polyvinylpyrrolidone, hence eliminating the use of albumen. The invention is of particular interest for vaccine compositions comprising attenuated live viruses such as oral vaccine against poliomyelitis.
REFERENCES:
patent: 3915794 (1975-10-01), Zygraich et al.
patent: 3919411 (1975-11-01), Glass et al.
patent: 5695770 (1997-12-01), Raychaudhuri et al.
patent: 5792643 (1998-08-01), Herrmann et al.
patent: 6379677 (2002-04-01), Klesius et al.
patent: 0273512 (1988-07-01), None
patent: 94 15636 (1994-07-01), None
The Merck Index: an Encyclopedia of Chemical and Drugs, Ninth edition, Windholz Ed., published by Merck & Co. Inc, Rahway, NJ, 1976, p. 7483.
The Merck Index: an Encyclopedia of Chemical and Drugs, Ninth edition, Windholz Ed., published by Merck & Co. Inc, Rahway, NJ, 1976, p. 996.
Françon Alain
Noël Catherine
Aventis Pasteur S.A.
McDonnell Boehnen Hulbert & Berghoff LLP.
Stucker Jeffrey
LandOfFree
Vaccine composition and stabilization method using high... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vaccine composition and stabilization method using high..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccine composition and stabilization method using high... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3585107